Journal Logo

ERRATUM

5α-Reductase inhibitors in androgenetic alopecia

Erratum

Current Opinion in Endocrinology & Diabetes and Obesity: February 2015 - Volume 22 - Issue 1 - p 73
doi: 10.1097/01.med.0000459968.14619.04
  • Free

In the recent article by Yim et al. no conflicts of interest were stated [1]. Dr Tosti wishes to correct that statement and disclose that she received payment from Merck as a speaker on the topic of hair and nails, her talks were not related to Propecia (finasteride).

REFERENCE

1. Yim E, Baquerizo Nole KL, Tosti A. 5α-Reductase inhibitors in androgenetic alopecia. Curr Opin Endocrinol Diabetes Obes. 2014; 21:493–498.
Copy © 2015 Wolters Kluwer Health, Inc. All rights reserved.